Skip to search.
 TSX Up 0.71% TSX Ventures Up 1.85%

AstraZeneca PLC (AZN)

-NYSE
31.67 Aug 28, 4:05PM EDT
|Pre-Market : 31.53 Down 0.14 (0.44%) 7:46AM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:31.67
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:37.86
Beta:0.85748
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:29.50 - 37.97
Volume:0
Avg Vol (3m):2,557,760
Market Cap:80.06B
P/E (ttm):67.82
EPS (ttm):0.47
Div & Yield:0.90 (4.43%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AZN 0.00%80.06B
GSK99.70B
MRK155.96B
PFE201.43B

Key Statistics

Forward P/E (1 yr):15.60
P/S (ttm):3.17
Ex-Dividend Date:18-Feb-15

Analysts

Annual EPS Est (Dec-15) :2.13
Quarterly EPS Est (Sep-15) :0.51
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):6.06

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection, and neuroscience diseases worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback